バイオプロセッシング技術の世界市場レポート 2025年

バイオプロセッシング技術市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.5％で499億2,000万米ドルに成長します。予測期間の成長は、バイオ製造能力の拡大、先端療法の出現、シングルユース・バイオプロセシングシステムの重要性の高まり、連続バイオプロセスの採用増加、戦略的提携やパートナーシップに起因しています。予測期間における世界の動向には、個別化医療と精密バイオプロセス、規制遵守と品質保証、バイオ医薬品製造の世界的拡大、環境持続可能性、共同研究およびパートナーシップが含まれます。

慢性疾患の罹患率の上昇は、今後のバイオプロセッシング技術市場の成長を大きく後押しすると予想されます。慢性疾患は、少なくとも1年間は続く長期的な健康状態であり、日常生活に支障をきたす可能性があるため、継続的な医療が必要となります。バイオプロセス技術は、慢性疾患の治療に不可欠な治療用タンパク質、多糖類、ワクチン、診断薬の開発に不可欠です。その結果、これらの疾病の有病率の増加がバイオプロセッシング技術市場の拡大を牽引することになります。例えば、スイスに本部を置く国連機関である世界保健機関（WHO）は、2024年2月に、2050年までに3,500万人以上のがん患者が新たに発生し、2022年の推定2,000万人から77％増加すると予測しました。このように、慢性疾患の罹患率の増加は、バイオプロセッシング技術市場の成長を促進すると予想されます。

ヘルスケア支出の増加は、バイオプロセッシング技術市場の拡大を促進すると予測されています。この支出には、個人や組織、政府がヘルスケア関連の商品やサービスに割り当てるリソースが含まれます。バイオプロセッシング技術は、医薬品や治療を含むヘルスケア分野の生産プロセスを最適化します。2022年11月のCIHIによると、カナダの医療費は0.8％増加し、2021年の3,280億米ドルから2022年には3,310億米ドルに達すると予測されています。したがって、医療費の急増がバイオプロセッシング技術市場の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 金利の影響
• インフレの影響
• 地政学の影響
• 新型コロナウイルス感染症と回復の市場への影響

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオプロセッシング技術 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバイオプロセッシング技術市場：成長率分析
• 世界のバイオプロセッシング技術市場の実績：規模と成長, 2019-2024
• 世界のバイオプロセッシング技術市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオプロセッシング技術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオプロセッシング技術市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物学的製剤の安全性試験
• 細胞培養
• 細胞増殖
• 細胞株の開発
• フローサイトメトリー
• タンジェンシャルフローろ過
• 世界のバイオプロセッシング技術市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• バイオシミラー
• 組み換えタンパク質
• その他の用途
• 世界のバイオプロセッシング技術市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオ医薬品企業
• 契約製造組織
• 学術調査機関
• 食品・飼料産業
• 契約調査機関
• 世界のバイオプロセッシング技術市場生物製剤安全性試験の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• エンドトキシン検査
• 無菌試験
• ウイルス安全性試験
• 世界のバイオプロセッシング技術市場細胞培養の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 哺乳類細胞培養
• 微生物細胞培養
• 昆虫細胞培養
• 世界のバイオプロセッシング技術市場、細胞増殖のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手動細胞増殖
• 自動細胞増殖
• 世界のバイオプロセッシング技術市場、細胞株開発のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハイブリドーマ技術
• 組み換え細胞株の開発
• 世界のバイオプロセッシング技術市場フローサイトメトリーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞選別
• 細胞分析
• 世界のバイオプロセッシング技術市場、接線流濾過のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 精密濾過
• 限外濾過

第7章 地域別・国別分析

• 世界のバイオプロセッシング技術市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオプロセッシング技術市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオプロセッシング技術市場：競合情勢
• バイオプロセッシング技術市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GE Healthcare
• Waters Corporation
• STADA Arzneimittel AG
• Bio-Rad Laboratories Inc.
• Applikon Biotechnology B.V.
• Agilent Technologies Inc.
• Solida Biotech GmbH
• Fujifilm Healthcare Corporation
• Catalent Inc.
• Asahi Kasei Medical Inc.
• Amgen Inc.
• Eppendorf AG
• Repligen Corporation
• Becton Dickinson and Company
• MilliporeSigma

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオプロセッシング技術市場2029：新たな機会を提供する国
• バイオプロセッシング技術市場2029：新たな機会を提供するセグメント
• バイオプロセッシング技術市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bioprocessing technology involves utilizing microbes, living cells, or components of living organisms to synthesize various biological products. This versatile process finds application in producing chemicals, food items, flavors, fuels, and medications, leveraging biocatalysts such as enzymes and microbes.

The primary products associated with bioprocessing technology include biologics safety testing, cell culture, cell expansion, cell line development, flow cytometry, and tangential flow filtration. Biologics safety testing encompasses a series of tests and protocols employed to assess the safety of biological products such as vaccines, gene therapies, and blood products before their approval for human use. These tests evaluate purity, potency, identity, and stability of these products. Bioprocess technology is utilized in antibiotics, biosimilars, recombinant proteins, and various other applications. It finds application across biopharmaceutical companies, contract manufacturing organizations, academic research institutes, the food and feed industry, as well as contract research organizations.

The bioprocessing technology software market research report is one of a series of new reports from The Business Research Company that provides bioprocessing technology software market statistics, including bioprocessing technology software industry global market size, regional shares, competitors with a bioprocessing technology software market share, detailed bioprocessing technology software market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocessing technology software industry. This bioprocessing technology software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioprocessing technology market size has grown rapidly in recent years. It will grow from $25.1 billion in 2024 to $29.06 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, expansion of biotechnology and life sciences industries, growing investment in research and development, globalization of the biopharmaceutical market, focus on cost-efficiency and process optimization.

The bioprocessing technology market size is expected to see rapid growth in the next few years. It will grow to $49.92 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to biomanufacturing capacity expansion, emergence of advanced therapies, rising importance of single-use bioprocessing systems, increased adoption of continuous bioprocessing, strategic collaborations and partnerships. Major trends in the forecast period include personalized medicine and precision bioprocessing, regulatory compliance and quality assurance, global expansion of biopharmaceutical production, environmental sustainability, collaborations and partnerships.

The rising incidence of chronic diseases is anticipated to significantly boost the growth of the bioprocessing technology market in the future. Chronic diseases are long-term health conditions that last for at least a year and can impair daily activities, necessitating ongoing medical care. Bioprocessing technologies are crucial for developing therapeutic proteins, polysaccharides, vaccines, and diagnostics essential for treating chronic diseases. Consequently, the growing prevalence of these diseases will drive the expansion of the bioprocessing technology market. For example, the World Health Organization, a United Nations agency based in Switzerland, projected in February 2024 that over 35 million new cancer cases will emerge by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Thus, the rising incidence of chronic diseases is expected to propel the growth of the bioprocessing technology market.

The escalating healthcare expenditure is anticipated to fuel the expansion of the bioprocessing technology market. This expenditure encompasses resources allocated by individuals, organizations, or governments toward healthcare-related goods and services. Bioprocessing technology optimizes production processes within the healthcare sector, spanning pharmaceuticals and medical treatments. According to the CIHI in November 2022, Canada's health spending is projected to elevate by 0.8%, reaching $331 billion in 2022 from $328 billion in 2021. Hence, the surge in healthcare expenditure is a driving force behind the bioprocessing technology market.

Technological advancement stands out as a prominent trend shaping the bioprocessing technology market. Key industry players are channeling efforts into enhancing bioprocess technologies to maintain their market standing. Univercells Technologies Inc., in October 2022, introduced the scale-X cell collect module, a part of the scale-X technology. This innovation streamlines the inoculation process for large-scale bioreactors through automation and intensification, reducing costs, operating time, footprint, and aseptic risks while ensuring high repeatability.

Major entities in the bioprocessing technology domain are dedicated to developing comprehensive bioprocessing solutions, such as bioprocessing platforms, to meet the increasing demand for enhanced yields and maximize profitability. Bioprocessing platforms encompass technologies and methods tailored for efficient large-scale biological material processing, especially in producing biopharmaceuticals. For instance, WuXi Biologics introduced WuXiUI in October 2023, a high-productivity bioprocessing platform enhancing mammalian cell line productivity and product quality. Utilizing an ultra-intensified intermittent-perfusion fed-batch strategy, WuXiUI achieves 3 to 6-fold productivity increases compared to conventional processes, catering to the need for yield enhancement, cost reduction, and adherence to environmental, social, and governance (ESG) considerations in bioprocess development.

In August 2024, Merck KGaA, a science and technology company based in Germany, acquired Mirus Bio for $600 million. This acquisition is intended to strengthen Merck KGaA's viral vector bioprocessing capabilities, allowing the company to offer integrated solutions across the entire manufacturing spectrum, from preclinical stages to commercial production. Mirus Bio, a biotechnology company located in the U.S., specializes in delivering innovative solutions for life sciences research and gene delivery applications.

Major companies operating in the bioprocessing technology market report are Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Lonza Group AG, GE Healthcare, Waters Corporation, STADA Arzneimittel AG, Bio-Rad Laboratories Inc., Applikon Biotechnology B.V., Agilent Technologies Inc., Solida Biotech GmbH, Fujifilm Healthcare Corporation, Catalent Inc., Asahi Kasei Medical Inc., Amgen Inc., Eppendorf AG, Repligen Corporation, Becton Dickinson and Company, MilliporeSigma, Novasep, Boehringer Ingelheim GmbH, Cytiva AB, Wuxi Biologics, AGC Biologics, Samsung Biologics, AbbVie Inc., Bristol Myers Squibb Company, Pfizer Inc., Roche Holding AG

North America was the largest region in the bioprocessing technology market in 2024. The regions covered in the bioprocessing technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bioprocessing technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The bioprocess technology market includes revenues earned by entities through media preparation, biocatalyst optimization, mass production, downstream processing, and purification. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprocess technology market also includes sales of process columns, dispersers or emulsifiers, screens or sieves, filters, fermenters or bioreactors, and process homogenizers which are used in bioprocess technology. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioprocessing Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioprocessing technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioprocessing technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioprocessing technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Biologics Safety Testing; Cell Culture; Cell Expansion; Cell Line Development; Flow Cytometry; Tangential Flow Filtration
• 2) By Application: Antibiotics; Biosimilars; Recombinant Proteins; Other Applications
• 3) By End Use: Biopharmaceutical Companies; Contract Manufacturing Organization; Academic Research Institutes; Food and Feed Industry; Contract Research Organization
• Subsegments:
• 1) By Biologics Safety Testing: Endotoxin Testing; Sterility Testing; Viral Safety Testing
• 2) By Cell Culture: Mammalian Cell Culture; Microbial Cell Culture; Insect Cell Culture
• 3) By Cell Expansion: Manual Cell Expansion; Automated Cell Expansion
• 4) By Cell Line Development: Hybridoma Technology; Recombinant Cell Line Development
• 5) By Flow Cytometry: Cell Sorting; Cell Analysis
• 6) By Tangential Flow Filtration: Microfiltration; Ultrafiltration
• Companies Mentioned: Thermo Fisher Scientific Inc.; Sartorius AG; Merck KGaA; Danaher Corporation; Lonza Group AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioprocessing Technology Market Characteristics

3. Bioprocessing Technology Market Trends And Strategies

4. Bioprocessing Technology Market - Macro Economic Scenario

• 4.1. Impact Of Interest Rates
• 4.2. Impact Of Inflation
• 4.3. Impact Of Geopolitics
• 4.4. Impact Of Covid And Recovery On The Market

5. Global Bioprocessing Technology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bioprocessing Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bioprocessing Technology Market Growth Rate Analysis
• 5.4. Global Bioprocessing Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bioprocessing Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bioprocessing Technology Total Addressable Market (TAM)

6. Bioprocessing Technology Market Segmentation

• 6.1. Global Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics Safety Testing
• Cell Culture
• Cell Expansion
• Cell Line Development
• Flow Cytometry
• Tangential Flow Filtration
• 6.2. Global Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Biosimilars
• Recombinant Proteins
• Other Applications
• 6.3. Global Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Contract Manufacturing Organization
• Academic Research Institutes
• Food and Feed Industry
• Contract Research Organization
• 6.4. Global Bioprocessing Technology Market, Sub-Segmentation Of Biologics Safety Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endotoxin Testing
• Sterility Testing
• Viral Safety Testing
• 6.5. Global Bioprocessing Technology Market, Sub-Segmentation Of Cell Culture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mammalian Cell Culture
• Microbial Cell Culture
• Insect Cell Culture
• 6.6. Global Bioprocessing Technology Market, Sub-Segmentation Of Cell Expansion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manual Cell Expansion
• Automated Cell Expansion
• 6.7. Global Bioprocessing Technology Market, Sub-Segmentation Of Cell Line Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hybridoma Technology
• Recombinant Cell Line Development
• 6.8. Global Bioprocessing Technology Market, Sub-Segmentation Of Flow Cytometry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Sorting
• Cell Analysis
• 6.9. Global Bioprocessing Technology Market, Sub-Segmentation Of Tangential Flow Filtration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microfiltration
• Ultrafiltration

7. Bioprocessing Technology Market Regional And Country Analysis

• 7.1. Global Bioprocessing Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bioprocessing Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioprocessing Technology Market

• 8.1. Asia-Pacific Bioprocessing Technology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioprocessing Technology Market

• 9.1. China Bioprocessing Technology Market Overview
• 9.2. China Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioprocessing Technology Market

• 10.1. India Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioprocessing Technology Market

• 11.1. Japan Bioprocessing Technology Market Overview
• 11.2. Japan Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioprocessing Technology Market

• 12.1. Australia Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioprocessing Technology Market

• 13.1. Indonesia Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioprocessing Technology Market

• 14.1. South Korea Bioprocessing Technology Market Overview
• 14.2. South Korea Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioprocessing Technology Market

• 15.1. Western Europe Bioprocessing Technology Market Overview
• 15.2. Western Europe Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioprocessing Technology Market

• 16.1. UK Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioprocessing Technology Market

• 17.1. Germany Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioprocessing Technology Market

• 18.1. France Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioprocessing Technology Market

• 19.1. Italy Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioprocessing Technology Market

• 20.1. Spain Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioprocessing Technology Market

• 21.1. Eastern Europe Bioprocessing Technology Market Overview
• 21.2. Eastern Europe Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioprocessing Technology Market

• 22.1. Russia Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioprocessing Technology Market

• 23.1. North America Bioprocessing Technology Market Overview
• 23.2. North America Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioprocessing Technology Market

• 24.1. USA Bioprocessing Technology Market Overview
• 24.2. USA Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioprocessing Technology Market

• 25.1. Canada Bioprocessing Technology Market Overview
• 25.2. Canada Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioprocessing Technology Market

• 26.1. South America Bioprocessing Technology Market Overview
• 26.2. South America Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioprocessing Technology Market

• 27.1. Brazil Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioprocessing Technology Market

• 28.1. Middle East Bioprocessing Technology Market Overview
• 28.2. Middle East Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioprocessing Technology Market

• 29.1. Africa Bioprocessing Technology Market Overview
• 29.2. Africa Bioprocessing Technology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bioprocessing Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bioprocessing Technology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioprocessing Technology Market Competitive Landscape And Company Profiles

• 30.1. Bioprocessing Technology Market Competitive Landscape
• 30.2. Bioprocessing Technology Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Bioprocessing Technology Market Other Major And Innovative Companies

• 31.1. GE Healthcare
• 31.2. Waters Corporation
• 31.3. STADA Arzneimittel AG
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. Applikon Biotechnology B.V.
• 31.6. Agilent Technologies Inc.
• 31.7. Solida Biotech GmbH
• 31.8. Fujifilm Healthcare Corporation
• 31.9. Catalent Inc.
• 31.10. Asahi Kasei Medical Inc.
• 31.11. Amgen Inc.
• 31.12. Eppendorf AG
• 31.13. Repligen Corporation
• 31.14. Becton Dickinson and Company
• 31.15. MilliporeSigma

32. Global Bioprocessing Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioprocessing Technology Market

34. Recent Developments In The Bioprocessing Technology Market

35. Bioprocessing Technology Market High Potential Countries, Segments and Strategies

• 35.1 Bioprocessing Technology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bioprocessing Technology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bioprocessing Technology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer